{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T14:01:18Z","timestamp":1776866478021,"version":"3.51.2"},"reference-count":34,"publisher":"e-Century Publishing Corporation","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Transl Res"],"DOI":"10.62347\/obnz4495","type":"journal-article","created":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:26:56Z","timestamp":1760167616000},"page":"7519-7529","source":"Crossref","is-referenced-by-count":2,"title":["Neutrophil-to-lymphocyte ratio and CD40 as diagnostic biomarkers for systemic lupus erythematosus and its disease activity"],"prefix":"10.62347","volume":"17","author":[{"given":"Juan","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"48694","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1146\/annurev-med-043021-032611","article-title":"Systemic lupus erythematosus: new diagnostic and therapeutic approaches","volume":"74","author":"Lazar","year":"2023","unstructured":"Lazar S and Kahlenberg JM. Systemic lupus erythematosus: new diagnostic and therapeutic approaches. Annu Rev Med 2023; 74: 339-352.","journal-title":"Annu Rev Med"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1001\/jama.2024.2315","article-title":"Systemic lupus erythematosus: a review","volume":"331","author":"Siegel","year":"2024","unstructured":"Siegel CH and Sammaritano LR. Systemic lupus erythematosus: a review. JAMA 2024; 331: 1480-1491.","journal-title":"JAMA"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"6578","DOI":"10.3390\/ijms24076578","article-title":"Advances in the pathogenesis and treatment of systemic lupus erythematosus","volume":"24","author":"Accapezzato","year":"2023","unstructured":"Accapezzato D, Caccavale R, Paroli MP, Gioia C, Nguyen BL, Spadea L and Paroli M. Advances in the pathogenesis and treatment of systemic lupus erythematosus. Int J Mol Sci 2023; 24: 6578.","journal-title":"Int J Mol Sci"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"103648","DOI":"10.1016\/j.autrev.2024.103648","article-title":"Immunopathogenesis of systemic lupus erythematosus: an update","volume":"23","author":"Arnaud","year":"2024","unstructured":"Arnaud L, Chasset F and Martin T. Immunopathogenesis of systemic lupus erythematosus: an update. Autoimmun Rev 2024; 23: 103648.","journal-title":"Autoimmun Rev"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1097\/BOR.0000000000000480","article-title":"Epidemiology of systemic lupus erythematosus: an update","volume":"30","author":"Stojan","year":"2018","unstructured":"Stojan G and Petri M. Epidemiology of systemic lupus erythematosus: an update. Curr Opin Rheumatol 2018; 30: 144-150.","journal-title":"Curr Opin Rheumatol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1136\/ard-2022-223741","article-title":"Pathogenesis of systemic lupus erythematosus: risks, mechanisms and therapeutic targets","volume":"82","author":"Crow","year":"2023","unstructured":"Crow MK. Pathogenesis of systemic lupus erythematosus: risks, mechanisms and therapeutic targets. Ann Rheum Dis 2023; 82: 999-1014.","journal-title":"Ann Rheum Dis"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s43556-024-00217-8","article-title":"Systemic lupus erythematosus: pathogenesis and targeted therapy","volume":"5","author":"Su","year":"2024","unstructured":"Su X, Yu H, Lei Q, Chen X, Tong Y, Zhang Z, Yang W, Guo Y and Lin L. Systemic lupus erythematosus: pathogenesis and targeted therapy. Mol Biomed 2024; 5: 54.","journal-title":"Mol Biomed"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41392-025-02168-0","article-title":"Systemic lupus erythematosus: updated insights on the pathogenesis, diagnosis, prevention and therapeutics","volume":"10","author":"Dai","year":"2025","unstructured":"Dai X, Fan Y and Zhao X. Systemic lupus erythematosus: updated insights on the pathogenesis, diagnosis, prevention and therapeutics. Signal Transduct Target Ther 2025; 10: 102.","journal-title":"Signal Transduct Target Ther"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/clc.23966","article-title":"High neutrophil-to-lymphocyte ratio as an early sign of cardiotoxicity in breast cancer patients treated with anthracycline","volume":"46","author":"Baruch","year":"2023","unstructured":"Baruch R, Zahler D, Zornitzki L, Arbel Y, Rozenbaum Z, Arnold JH, Raphael A, Khoury S, Banai S, Topilsky Y, Kapusta L and Laufer-Perl M. High neutrophil-to-lymphocyte ratio as an early sign of cardiotoxicity in breast cancer patients treated with anthracycline. Clin Cardiol 2023; 46: 328-335.","journal-title":"Clin Cardiol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1115031","DOI":"10.3389\/fimmu.2023.1115031","article-title":"The clinical value of neutrophil-to-lymphocyte ratio (NLR), systemic immune-inflammation index (SII), platelet-to-lymphocyte ratio (PLR) and systemic inflammation response index (SIRI) for predicting the occurrence and severity of pneumonia in patients with intracerebral hemorrhage","volume":"14","author":"Wang","year":"2023","unstructured":"Wang RH, Wen WX, Jiang ZP, Du ZP, Ma ZH, Lu AL, Li HP, Yuan F, Wu SB, Guo JW, Cai YF, Huang Y, Wang LX and Lu HJ. The clinical value of neutrophil-to-lymphocyte ratio (NLR), systemic immune-inflammation index (SII), platelet-to-lymphocyte ratio (PLR) and systemic inflammation response index (SIRI) for predicting the occurrence and severity of pneumonia in patients with intracerebral hemorrhage. Front Immunol 2023; 14: 1115031.","journal-title":"Front Immunol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13317-019-0114-8","article-title":"Neutrophil\/lymphocyte ratio and lymphocyte\/monocyte ratio in ulcerative colitis as non-invasive biomarkers of disease activity and severity","volume":"10","author":"Okba","year":"2019","unstructured":"Okba AM, Amin MM, Abdelmoaty AS, Ebada HE, Kamel AH, Allam AS and Sobhy OM. Neutrophil\/lymphocyte ratio and lymphocyte\/monocyte ratio in ulcerative colitis as non-invasive biomarkers of disease activity and severity. Auto Immun Highlights 2019; 10: 4.","journal-title":"Auto Immun Highlights"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"423","DOI":"10.3389\/fimmu.2019.00423","article-title":"Caught in a Trap? Proteomic analysis of neutrophil extracellular traps in rheumatoid arthritis and systemic lupus erythematosus","volume":"10","author":"Chapman","year":"2019","unstructured":"Chapman EA, Lyon M, Simpson D, Mason D, Beynon RJ, Moots RJ and Wright HL. Caught in a Trap? Proteomic analysis of neutrophil extracellular traps in rheumatoid arthritis and systemic lupus erythematosus. Front Immunol 2019; 10: 423.","journal-title":"Front Immunol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1136\/annrheumdis-2018-eular.4730","article-title":"FRI0311 The effect of b cell targeted therapies on autoantibodies and excessive neutrophil extracellular trap formation in systemic lupus erythematosus patients","volume":"77","author":"Van Dam","year":"2018","unstructured":"Van Dam L, Osmani Z, Kraaij T, Kamerling S, Bakker J, Scherer H, Rabelink T, Voll R, Isenberg D and van Kooten C. FRI0311 The effect of b cell targeted therapies on autoantibodies and excessive neutrophil extracellular trap formation in systemic lupus erythematosus patients. Ann Rheum Dis 2018; 77: 692.","journal-title":"Ann Rheum Dis"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Rich RR and Chaplin DD. The human immune response. Clinical Immunology 2019; 3-17, e1.","DOI":"10.1016\/B978-0-7020-6896-6.00001-6"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1007\/s10238-024-01438-5","article-title":"A systematic review and meta-analysis of the diagnostic accuracy of the neutrophil-to-lymphocyte ratio and the platelet-to-lymphocyte ratio in systemic lupus erythematosus","volume":"24","author":"Zinellu","year":"2024","unstructured":"Zinellu A, Paliogiannis P and Mangoni AA. A systematic review and meta-analysis of the diagnostic accuracy of the neutrophil-to-lymphocyte ratio and the platelet-to-lymphocyte ratio in systemic lupus erythematosus. Clin Exp Med 2024; 24: 170.","journal-title":"Clin Exp Med"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Dimberg A, Karampatzakis A, Tuit S, Ramachandran M, Fotaki G, Hooren Lv, Huang H, Lugano R, Aura K and Ellmark P. Abstract A128: tumor endothelial cells say IDO to CD40-stimulating immunotherapy. Cancer Immunol Res 2019; 7: A128.","DOI":"10.1158\/2326-6074.CRICIMTEATIAACR18-A128"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"927","DOI":"10.3390\/cells8080927","article-title":"Targeting the CD40-CD154 signaling pathway for treatment of autoimmune arthritis","volume":"8","author":"JH","year":"2019","unstructured":"Lai JH, Luo SF and Ho LJ. Targeting the CD40-CD154 signaling pathway for treatment of autoimmune arthritis. Cells 2019; 8: 927.","journal-title":"Cells"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"10702","DOI":"10.1038\/s41598-023-37749-y","article-title":"Higher CD4+CD40+ T cells (Th40 cells) associate with systemic lupus erythematosus activity","volume":"13","author":"Zhu","year":"2023","unstructured":"Zhu L, Song G, Chen X, Zhang Y, Cui Y, Qiao J, Huang X, Li X, Liu X, Zeng X, Li Y, Wang L and Li B. Higher CD4+CD40+ T cells (Th40 cells) associate with systemic lupus erythematosus activity. Sci Rep 2023; 13: 10702.","journal-title":"Sci Rep"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Wu C, Yuan Q, Mo Y, Liang L, Wang C, Jiang Y and Lan Y. Association of CD40 gene polymorphisms and serum CD40 levels with the pathogenesis of systemic lupus erythematosus. J Dermatol 2016; 12-16.","DOI":"10.1186\/s12863-015-0279-8"},{"key":"ref19","unstructured":"Hawker G, Gabriel S, Bombardier C, Goldsmith C, Caron D and Gladman D. A reliability study of SLEDAI: a disease activity index for systemic lupus erythematosus. J Rheumatol 1993; 20: 657-660."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1097\/RHU.0000000000001939","article-title":"Short-term accrual 2019 European League Against Rheumatism\/American College of Rheumatology Domains and Systemic Lupus International Collaborating Clinics\/American College of Rheumatology Damage in lupus patients with and without nephritis at disease onset","volume":"29","author":"Munhoz","year":"2023","unstructured":"Munhoz GA, Aikawa NE, Silva CA, Pasoto SG, Pedrosa TN, Seguro LPC, Bonfa E and Borba EF. Short-term accrual 2019 European League Against Rheumatism\/American College of Rheumatology Domains and Systemic Lupus International Collaborating Clinics\/American College of Rheumatology Damage in lupus patients with and without nephritis at disease onset. J Clin Rheumatol 2023; 29: 190-195.","journal-title":"J Clin Rheumatol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1007\/s11883-023-01149-4","article-title":"Atherosclerosis in systemic lupus erythematosus","volume":"25","author":"Tobin","year":"2023","unstructured":"Tobin R, Patel N, Tobb K, Weber B, Mehta PK and Isiadinso I. Atherosclerosis in systemic lupus erythematosus. Curr Atheroscler Rep 2023; 25: 819-827.","journal-title":"Curr Atheroscler Rep"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/s41581-023-00797-8","article-title":"Vascular damage in systemic lupus erythematosus","volume":"20","author":"Ambler","year":"2024","unstructured":"Ambler WG and Kaplan MJ. Vascular damage in systemic lupus erythematosus. Nat Rev Nephrol 2024; 20: 251-265.","journal-title":"Nat Rev Nephrol"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Muñoz-Grajales C, Yilmaz EB, Svenungsson E and Touma Z. Systemic lupus erythematosus and damage: what has changed over the past 20 years? Best Pract Res Clin Rheumatol 2023; 37: 101893.","DOI":"10.1016\/j.berh.2023.101893"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.3899\/jrheum.2022-1135","article-title":"Variations of C3 and C4 before and during pregnancy in systemic lupus erythematosus: association with disease flares and obstetric outcomes","volume":"50","author":"Crisafulli","year":"2023","unstructured":"Crisafulli F, Andreoli L, Zucchi D, Reggia R, Gerardi MC, Lini D, Tani C, Zatti S, Franceschini F, Mosca M and Tincani A. Variations of C3 and C4 before and during pregnancy in systemic lupus erythematosus: association with disease flares and obstetric outcomes. J Rheumatol 2023; 50: 1296-1301.","journal-title":"J Rheumatol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"103479","DOI":"10.1016\/j.autrev.2023.103479","article-title":"Recommendations for the use of anti-dsDNA autoantibodies in the diagnosis and follow-up of systemic lupus erythematosus - a proposal from an expert panel","volume":"22","author":"Rojo","year":"2023","unstructured":"Rojo R, Calvo Alén J, Prada Á, Valor S, Roy G, López-Hoyos M, Cervera R, Sánchez Mateos P and Jurado Roger A. Recommendations for the use of anti-dsDNA autoantibodies in the diagnosis and follow-up of systemic lupus erythematosus - a proposal from an expert panel. Autoimmun Rev 2023; 22: 103479.","journal-title":"Autoimmun Rev"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"269","DOI":"10.7754\/Clin.Lab.2014.140927","article-title":"Neutrophil- and platelet-to-lymphocyte ratios are correlated with disease activity in rheumatoid arthritis","volume":"61","author":"Fu","year":"2015","unstructured":"Fu H, Qin B, Hu Z, Ma N, Yang M, Wei T, Tang Q, Huang Y, Huang F, Liang Y, Yang Z and Zhong R. Neutrophil- and platelet-to-lymphocyte ratios are correlated with disease activity in rheumatoid arthritis. Clin Lab 2015; 61: 269-273.","journal-title":"Clin Lab"},{"key":"ref27","unstructured":"Oehadian A, Suryadinata H, Dewi S, Pramudyo R and Alisjahbana B. The role of neutrophyl lymphocyte count ratio as an inflammatory marker in systemic lupus erythematosus. Acta Med Indones 2013; 45: 170-174."},{"key":"ref28","unstructured":"Li L, Xia Y, Chen C, Cheng P and Peng C. Neutrophil-lymphocyte ratio in systemic lupus erythematosus disease: a retrospective study. Int J Clin Exp Med 2015; 8: 11026."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1136\/annrheumdis-2018-eular.3161","article-title":"FRI0641 Detection of changes in sle disease activity is highly improved with SLE-DAS as compared to sledai: derivation and preliminary validation of the SLE disease activity score (SLE-DAS)","volume":"77","author":"Jesus","year":"2018","unstructured":"Jesus D, Matos A, Henriques C, Zen M, Doria A, Jap D and Inês L. FRI0641 Detection of changes in sle disease activity is highly improved with SLE-DAS as compared to sledai: derivation and preliminary validation of the SLE disease activity score (SLE-DAS). Ann Rheum Dis 2018; 77: 842-843.","journal-title":"Ann Rheum Dis"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"372","DOI":"10.3109\/14397595.2015.1091136","article-title":"Neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) were useful markers in assessment of inflammatory response and disease activity in SLE patients","volume":"26","author":"Qin","year":"2016","unstructured":"Qin B, Ma N, Tang Q, Wei T, Yang M, Fu H, Hu Z, Liang Y, Yang Z and Zhong R. Neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) were useful markers in assessment of inflammatory response and disease activity in SLE patients. Mod Rheumatol 2016; 26: 372-376.","journal-title":"Mod Rheumatol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"58","DOI":"10.4049\/jimmunol.1900043","article-title":"Treatment with a CD40 antagonist antibody reverses severe proteinuria and loss of saliva production and restores glomerular morphology in murine systemic lupus erythematosus","volume":"203","author":"Perper","year":"2019","unstructured":"Perper SJ, Westmoreland SV, Karman J, Twomey R, Seagal J, Wang R, McRae BL and Clarke SH. Treatment with a CD40 antagonist antibody reverses severe proteinuria and loss of saliva production and restores glomerular morphology in murine systemic lupus erythematosus. J Immunol 2019; 203: 58-75.","journal-title":"J Immunol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"558","DOI":"10.4049\/jimmunol.2100792","article-title":"Combination CTLA4Ig and Anti-CD40 ligand treatment modifies t and b cell metabolic profiles and promotes b cell receptor remodeling in a mouse model of systemic lupus erythematosus","volume":"210","author":"Raparia","year":"2023","unstructured":"Raparia C, Quach TD, Zeumer-Spataro L, Choi SC, Yi Z, Zhang W, Morel L and Davidson A. Combination CTLA4Ig and Anti-CD40 ligand treatment modifies t and b cell metabolic profiles and promotes b cell receptor remodeling in a mouse model of systemic lupus erythematosus. J Immunol 2023; 210: 558-567.","journal-title":"J Immunol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/s10067-018-4349-y","article-title":"The association of CD40 polymorphism (rs1883832C\/T) and soluble CD40 with the risk of systemic lupus erythematosus among Egyptian patients","volume":"38","author":"Mousa","year":"2019","unstructured":"Mousa TG, Omar HH, Emad R, Salama MI, Omar W, Fawzy M and Hassoba HM. The association of CD40 polymorphism (rs1883832C\/T) and soluble CD40 with the risk of systemic lupus erythematosus among Egyptian patients. Clin Rheumatol 2019; 38: 777-784.","journal-title":"Clin Rheumatol"}],"container-title":["American Journal of Translational Research"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ajtr\/17\/9\/ajtr0167151.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T06:18:00Z","timestamp":1769062680000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajtr\/17\/9\/ajtr0167151.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":34,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.62347\/obnz4495","relation":{},"ISSN":["1943-8141"],"issn-type":[{"value":"1943-8141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]}}}